Herriot Tabuteau is the founder of Axsome Therapeutics. The company focuses on developing drugs for brain disorders.
Herriot Tabuteau is the founder and CEO of Axsome Therapeutics, a drug development company established in 2012. The company focuses on developing drugs for brain disorders, including depression and Alzheimer's disease. Tabuteau self-funded the company with the help of friends and family, choosing not to take venture capital. Axsome Therapeutics currently has three drugs on the market and five in the pipeline, and trades on the Nasdaq with a market capitalization of $6.1 billion.
Full founder directory · Investor directory · Company funding database · Fundraising library